1. Home
  2. PAI vs ICCC Comparison

PAI vs ICCC Comparison

Compare PAI & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Investment Grade Income Fund Inc.

PAI

Western Asset Investment Grade Income Fund Inc.

SELL

Current Price

$11.50

Market Cap

114.7M

Sector

Finance

ML Signal

SELL

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$10.37

Market Cap

93.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAI
ICCC
Founded
1973
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.7M
93.1M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
PAI
ICCC
Price
$11.50
$10.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 21.9K
7.4K
Earning Date
01-01-0001
11-12-2026
Dividend Yield
★ 4.78%
N/A
EPS Growth
N/A
★ 53.85
EPS
N/A
★ 0.41
Revenue
N/A
★ $26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$25.34
Revenue Growth
N/A
★ 51.64
52 Week Low
$11.24
$4.52
52 Week High
$12.95
$12.10

Technical Indicators

Market Signals
Indicator
PAI
ICCC
Relative Strength Index (RSI) 48.01 51.34
Support Level $11.24 $9.45
Resistance Level $12.35 $10.82
Average True Range (ATR) 0.08 0.23
MACD 0.03 0.03
Stochastic Oscillator 76.92 50.58

Price Performance

Historical Comparison
PAI
ICCC

About PAI Western Asset Investment Grade Income Fund Inc.

Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. Its primary investment objective is to seek a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. To a lesser extent, the fund also invests in privately placed debt securities and in certain equity securities. Capital appreciation is its secondary investment objective. The fund invests a majority of its net assets in fixed income securities that are rated in the Baa or BBB categories or above at the time of purchase by one or more Nationally Recognized Statistical Rating Organizations (NRSROs) or unrated securities of comparable quality at the time of purchase (as determined by the investment adviser).

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: